Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Renal Failure

  Free Subscription


Articles published in Curr Opin Nephrol Hypertens

Retrieve available abstracts of 32 articles:
HTML format



Single Articles


    September 2021
  1. CANAUD B
    Recent advances in dialysis membranes.
    Curr Opin Nephrol Hypertens. 2021 Sep 1. pii: 00041552-900000000-98966.
    PubMed     Abstract available


  2. ZABETIAN A, Coca SG
    Plasma and urine biomarkers in chronic kidney disease: closer to clinical application.
    Curr Opin Nephrol Hypertens. 2021 Sep 1. pii: 00041552-900000000-98967.
    PubMed     Abstract available


    August 2021
  3. TIAN N, Chen N, Li PK
    Depression in dialysis.
    Curr Opin Nephrol Hypertens. 2021 Aug 26. pii: 00041552-900000000-98971.
    PubMed     Abstract available


  4. LIGHTFOOT CJ, Howell M, Smith AC
    How to assess quality of life in persons with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Aug 23. pii: 00041552-900000000-98972.
    PubMed     Abstract available


    June 2021
  5. SAEED F, Shah AY, Allen RJ, Epstein RM, et al
    Communication principles and practices for making shared decisions about renal replacement therapy: a review of the literature.
    Curr Opin Nephrol Hypertens. 2021 Jun 18. pii: 00041552-900000000-98977.
    PubMed     Abstract available


    May 2021
  6. COHEN-BUCAY A, Francis JM, Gordon CE
    Progress in hepatitis C virus management in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 May 28. pii: 00041552-900000000-98979.
    PubMed     Abstract available


  7. PARVATHAREDDY VP, Ella KM, Shah M, Navaneethan SD, et al
    Treatment options for managing obesity in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 May 25. pii: 00041552-900000000-98980.
    PubMed     Abstract available


  8. SMEIJER JD, Kohan DE, Webb DJ, Dhaun N, et al
    Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 May 10. pii: 00041552-900000000-98984.
    PubMed     Abstract available


  9. CHALUPSKY M, Goodson DA, Gamboa JL, Roshanravan B, et al
    New insights into muscle function in chronic kidney disease and metabolic acidosis.
    Curr Opin Nephrol Hypertens. 2021;30:369-376.
    PubMed     Abstract available


  10. VLASSCHAERT C, Sidhu B, Silver SA
    Sodium/glucose cotransporter 2 inhibitors in chronic kidney disease and heart failure: ready for prime time in patients without diabetes.
    Curr Opin Nephrol Hypertens. 2021;30:361-368.
    PubMed     Abstract available


  11. ARIF H, Yadav A
    Approach to stable angina in patients with advanced chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021;30:339-345.
    PubMed     Abstract available


    April 2021
  12. DAMRATH JG, Creecy A, Wallace JM, Moe SM, et al
    The impact of advanced glycation end products on bone properties in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Apr 28. pii: 00041552-900000000-98985.
    PubMed     Abstract available


    January 2021
  13. CLARK-CUTAIA MN, Rivera E, Iroegbu C, Squires A, et al
    Disparities in chronic kidney disease-the state of the evidence.
    Curr Opin Nephrol Hypertens. 2021 Jan 13. pii: 00041552-900000000-99003.
    PubMed     Abstract available


  14. KOURI AM, Rheault MN
    Cardiovascular disease in children with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Jan 13. pii: 00041552-900000000-99002.
    PubMed     Abstract available


  15. PREMACHANDRA KH, Day RO, Roberts DM
    Managing hyperuricemia and gout in chronic kidney disease: a clinical conundrum.
    Curr Opin Nephrol Hypertens. 2021;Publish Ahead of Print.
    PubMed     Abstract available


    December 2020
  16. NAIR D, Malhotra S, Lupu D, Harbert G, et al
    Challenges in communication, prognostication and dialysis decision-making in the COVID-19 pandemic: implications for interdisciplinary care during crisis settings.
    Curr Opin Nephrol Hypertens. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  17. SOOMRO QH, Charytan DM
    Cardiovascular autonomic nervous system dysfunction in chronic kidney disease and end-stage kidney disease: disruption of the complementary forces.
    Curr Opin Nephrol Hypertens. 2020;Publish Ahead of Print.
    PubMed     Abstract available


    November 2020
  18. ZARANTONELLO D, Rhee CM, Kalantar-Zadeh K, Brunori G, et al
    Novel conservative management of chronic kidney disease via dialysis-free interventions.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000670.
    PubMed     Abstract available


  19. TANTISATTAMO E, Kalantar-Zadeh K
    Novel therapeutic approaches in chronic kidney disease, uremia and kidney transplantation: past, present and future.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000677.
    PubMed    


  20. STREJA E, Norris KC, Budoff MJ, Hashemi L, et al
    The quest for cardiovascular disease risk prediction models in patients with nondialysis chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000672.
    PubMed     Abstract available


  21. FERREY AJ, Hanna R, Reddy UG, Tantisattamo E, et al
    Novel therapeutic approaches for COVID-19 in chronic kidney disease and transplant.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000671.
    PubMed     Abstract available


  22. TANTISATTAMO E, Leventhal JR, Mathew JM, Gallon L, et al
    Chimerism and tolerance: past, present and future strategies to prolong renal allograft survival.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000666.
    PubMed     Abstract available


  23. HANNA RM, Ferrey A, Rhee CM, Sam R, et al
    Building a hemodiafiltration system from readily available components for continuous renal replacement therapy under disasters and pandemics: preparing for an acute kidney injury surge during COVID-19.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000658.
    PubMed     Abstract available


  24. TANTISATTAMO E, Kalantar-Zadeh K, Halleck F, Duettmann W, et al
    Novel approaches to sarcopenic obesity and weight management before and after kidney transplantation.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000673.
    PubMed     Abstract available


  25. ONG SC, Rhee CM
    Novel management of diabetes in kidney transplantation.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000665.
    PubMed     Abstract available


  26. MUREA M
    Precision medicine approach to dialysis including incremental and decremental dialysis regimens.
    Curr Opin Nephrol Hypertens. 2020 Nov 6. doi: 10.1097/MNH.0000000000000667.
    PubMed     Abstract available


  27. SUMIDA K, Lau WL, Kovesdy CP, Kalantar-Zadeh K, et al
    Microbiome modulation as a novel therapeutic approach in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2020 Nov 2. doi: 10.1097/MNH.0000000000000661.
    PubMed     Abstract available


  28. JUDGE PK, Haynes R
    taleNeprilysin and Neprilysin inhibition in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2020 Nov 2. doi: 10.1097/MNH.0000000000000659.
    PubMed     Abstract available


  29. HUR L, McIntyre CW
    Current and novel imaging techniques to evaluate myocardial dysfunction during hemodialysis.
    Curr Opin Nephrol Hypertens. 2020;29:555-563.
    PubMed     Abstract available


  30. CHUKWU CA, Middleton R, Kalra PA
    Recurrent glomerulonephritis after renal transplantation.
    Curr Opin Nephrol Hypertens. 2020;29:636-644.
    PubMed     Abstract available


  31. VIRAMONTES-HORNER D, Taal MW
    Nutritional status assessment: a neglected biomarker in persons with end-stage kidney disease.
    Curr Opin Nephrol Hypertens. 2020;29:547-554.
    PubMed     Abstract available


    January 2020
  32. KELLER RW JR, Kopple JD, Kalantar-Zadeh K
    Perspiration interventions for conservative management of kidney disease and uremia.
    Curr Opin Nephrol Hypertens. 2020;29:57-63.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: